Experience of Applying TNF--inhibitors (Adalimumab and Etanercept) while Treating a Patient with Juvenile Arthritis and Eye Failure
The article presents a seven-year-long monitoring of a patient with juvenile arthritis and eye problems who is refractory to the standard basic immunosuppressive drugs therapy. High efficiency of both tumor necrosis factor (TNF) receptor blocker etanercept and recombinant antibody to TNF- adalimuma...
Saved in:
Main Author: | T. I. Korovkina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Union of pediatricians of Russia
2015-11-01
|
Series: | Педиатрическая фармакология |
Subjects: | |
Online Access: | https://www.pedpharma.ru/jour/article/view/517 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Etanercept In the treatment of AA-amyloidosis in juvenile rheumatoid arthritis
by: H Mihels
Published: (2004-08-01) -
EFFICACY OF USE OF TNF INHIBITOR ADALIMUMAB IN A FEMALE PATIENT WITH CHRONIC UVEITIS IN THE ONSET OF JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Pavkhun, et al.
Published: (2016-02-01) -
Experience of etanercept treatment in juvenile ankylosing spondyloarthritis
by: A. N. Fetisova, et al.
Published: (2013-03-01) -
Evaluation of Efficacy and Safety of Etanercept and Etanercept + Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2016-01-01) -
ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH THE JUVENILE IDIOPATHIC ARTHRITIS TREATED BY THE ETANERCEPT
by: A. N. Fetisova, et al.
Published: (2014-07-01)